Clinical Trial Update: Subunit Vaccine Against Herpes Zoster in RA Patients Treated With JAK-inhibitors (VACCIMIL-ZOSTER) [Phase 4]

View source ↗

Summary

Phase 4 trial update on a subunit herpes zoster vaccine in rheumatoid arthritis patients treated with JAK inhibitors; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Snippet

Sponsor: Region Skane | Conditions: Rheumatoid Arthritis, Healthy Controls | Phase 4 | Status: COMPLETED